The licence enables the Company to support its customers and partners in the fields of cell and gene therapy and vaccine development with GMP-grade synthetic DNA for their clinical programs.

Bis-(3′-5′)-cyclic dimeric GMP (c-di-GMP) is a ubiquitous bacterial second messenger that is involved in the regulation of virulence, cell surface-associated traits and biofilm formation.